Portfolio Diversification
Range
Most Diversified
30 instruments
March 2, 2022
Least Diversified
0 instruments
February 1, 2022
Average
29.2 instruments
Most Consistent Holdings
Top 5
JNJ97.56%
MRK97.56%
PFE97.56%
AMGN97.56%
ABBV97.56%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since February 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Eli Lilly (LLY) | 3.91% | 3.42% | 97.56% | - |
 Bridgebio (BBIO) | 3.88% | 4.5% | 72.86% | - |
 Vertex (VRTX) | 3.62% | 3.3% | 97.56% | - |
 ImmunoGen Inc (IMGN) | 3.36% | 0% | 57.56% | 2/14/2024 |
| Merck (MRK) | 3.33% | 2.66% | 97.56% | - |
 Regeneron (REGN) | 3.25% | 2.16% | 97.56% | - |
| Johnson & Johnson (JNJ) | 3.24% | 3.01% | 97.56% | - |
 Gilead Sciences (GILD) | 3.24% | 3.75% | 97.56% | - |
 Exact Sciences (EXAS) | 3.22% | 4.98% | 97.56% | - |
 Guardant Health (GH) | 3.18% | 6.42% | 97.56% | - |
| AbbVie (ABBV) | 3.15% | 3.19% | 97.56% | - |
| Amgen (AMGN) | 3.14% | 3.27% | 97.56% | - |
 Bristol-Myers Squibb (BMY) | 3.09% | 2.57% | 97.56% | - |
 Illumina (ILMN) | 2.98% | 2.56% | 97.39% | - |
 CRISPR Therapeutics (CRSP) | 2.93% | 0% | 83.95% | 12/26/2024 |
| Pfizer (PFE) | 2.91% | 2.84% | 97.56% | - |
 Revolution Medicines (RVMD) | 2.4% | 3.24% | 72.86% | - |
 Argenx (ARGX) | 2.39% | 2.86% | 72.86% | - |
 Blueprint Medicines (BPMC) | 2.38% | 4.47% | 72.86% | - |
 Exelixis (EXEL) | 2.37% | 3.57% | 67.65% | - |
 Iovance (IOVA) | 2.36% | 0.88% | 72.86% | - |
 Syndax (SNDX) | 2.16% | 2.48% | 72.86% | - |
 Mirati Therapeutics Inc (MRTX) | 1.7% | 0% | 56.39% | 1/31/2024 |
 Arcellx (ACLX) | 1.65% | 2.97% | 43.61% | - |
 SpringWorks Therapeutics (SWTX) | 1.54% | 3.99% | 43.61% | - |
 BeiGene (ONC) | 1.49% | 0% | 53.95% | 1/2/2024 |
 TG Therapeutics (TGTX) | 1.42% | 4.1% | 38.4% | - |
 AstraZeneca (AZN) | 1.38% | 3.2% | 43.61% | - |
 Fate Therapeutics (FATE) | 1.34% | 0% | 53.95% | 1/2/2024 |
 Seagen Inc (SGEN) | 1.25% | 0% | 27.98% | 12/18/2023 |
 BD (BDX) | 1.24% | 2.27% | 43.61% | - |
 Crinetics (CRNX) | 1.21% | 0% | 30% | 12/26/2024 |
 Zai Lab (ZLAB) | 1.13% | 4.03% | 42.86% | - |
 Legend Biotech (LEGN) | 1.03% | 0% | 29.24% | 1/2/2024 |
 Incyte (INCY) | 1.01% | 0% | 24.71% | 1/12/2023 |
 BioNTech SE (BNTX) | 0.94% | 0% | 24.71% | 1/12/2023 |
 2Seventy Bio (TSVT) | 0.93% | 0% | 24.71% | 1/12/2023 |
 Option Care Health (OPCH) | 0.92% | 0% | 30% | 12/26/2024 |
 Rocket (RCKT) | 0.85% | 0% | 30% | 12/26/2024 |
 Arvinas (ARVN) | 0.85% | 0% | 30% | 12/26/2024 |
 Agenus (AGEN) | 0.83% | 0% | 24.71% | 1/12/2023 |
 LabCorp (LH) | 0.82% | 0% | 24.71% | 1/12/2023 |
 GlaxoSmithKline (GSK) | 0.77% | 0% | 24.71% | 1/12/2023 |
 MannKind (MNKD) | 0.76% | 0% | 29.24% | 1/2/2024 |
 Sorrento (SRNE) | 0.66% | 0% | 24.71% | 1/12/2023 |
 Celldex (CLDX) | 0.63% | 0% | 29.24% | 1/2/2024 |
 Inovio (INO) | 0.63% | 0% | 24.71% | 1/12/2023 |
 Clovis Oncology Inc (CLVSQ) | 0.56% | 0% | 23.03% | 12/22/2022 |
 Halozyme (HALO) | 0.49% | 3.32% | 13.61% | - |
 Scholar Rock (SRRK) | 0.46% | 3.25% | 13.61% | - |
 Surface Oncology Inc (SURF) | 0.41% | 0% | 23.03% | 12/22/2022 |
 Merus (MRUS) | 0.41% | 3.86% | 13.61% | - |
 Invitae Corp (NVTAQ) | 0.31% | 0% | 24.71% | 1/12/2023 |
 Janux (JANX) | 0.29% | 1.56% | 13.61% | - |
 Curis (CRIS) | 0.29% | 0% | 23.03% | 12/22/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Exact Sciences (EXAS) | 6.26% | 5.15% |
| Illumina (ILMN) | 3.69% | 4.17% |
| Scholar Rock (SRRK) | 4.72% | 4.1% |
| Guardant Health (GH) | 5.47% | 4.06% |
| Iovance (IOVA) | 3.5% | 3.67% |
| Revolution Medicines (RVMD) | 2.45% | 3.54% |
| Eli Lilly (LLY) | 1.71% | 3.46% |
| Arcellx (ACLX) | 2.82% | 3.45% |
| Merck (MRK) | 3.47% | 3.42% |
| Janux (JANX) | 3.87% | 3.39% |
| Pfizer (PFE) | 4.88% | 3.27% |
| Bridgebio (BBIO) | 1.42% | 3.23% |
| Regeneron (REGN) | 3.22% | 3.2% |
| TG Therapeutics (TGTX) | 2.05% | 3.15% |
| Gilead Sciences (GILD) | 2.42% | 3.15% |
| SpringWorks Therapeutics (SWTX) | 3.48% | 3.09% |
| Blueprint Medicines (BPMC) | 2.02% | 3.05% |
| Argenx (ARGX) | 2.14% | 3.04% |
| Bristol-Myers Squibb (BMY) | 3.69% | 3.04% |
| AbbVie (ABBV) | 2.8% | 3.03% |
| BD (BDX) | 3.58% | 3.02% |
| Vertex (VRTX) | 1.98% | 3.01% |
| Halozyme (HALO) | 3.28% | 2.98% |
| Amgen (AMGN) | 3.03% | 2.98% |
| Syndax (SNDX) | 5.42% | 2.94% |
| AstraZeneca (AZN) | 3.33% | 2.91% |
| Merus (MRUS) | 3.26% | 2.9% |
| Zai Lab (ZLAB) | 3.28% | 2.89% |
| Johnson & Johnson (JNJ) | 3.51% | 2.84% |
| Exelixis (EXEL) | 2.1% | 2.82% |